Paper Details

  1. Home
  2. Paper Details

Examination of the mechanism of action of two pre-quit pharmacotherapies for smoking cessation.

Author: FergusonStuart G, LuWenying, SchüzNatalie, WaltersJulia A E, WellsGudrun P

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

While treatments for quitting smoking are available, many people still fail to quit. Using nicotine patches for a short time before quitting has shown promise in helping people quit. This study aims to understand how two medications used before quitting, varenicline and nicotine patches, work to improve the success of quitting.
Paper Details　
Original Abstract of the Article :
There is substantial scope for improvement in the current arsenal of smoking cessation methods and techniques: even when front-line cessation treatments are utilized, smokers are still more likely to fail than to succeed. Studies testing the incremental benefit of using nicotine patch for 1-4 weeks ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687305/

データ提供：米国国立医学図書館（NLM）

Pre-Quit Pharmacotherapies: A New Frontier in Smoking Cessation

This research explores the potential of pre-quit pharmacotherapies, such as varenicline and nicotine patches, as a new frontier in smoking cessation. It's like venturing into an uncharted desert landscape, seeking new and innovative approaches to help people break free from the grip of nicotine addiction.

Pre-Quit Therapies: A Path to Freedom from Nicotine

This study investigates the mechanisms of action of pre-quit therapies, aiming to optimize their effectiveness in helping smokers quit. It's like mapping out a new trail through the desert of nicotine addiction, seeking the most effective route to liberation. The research highlights the potential of pre-quit therapies to improve success rates in smoking cessation, offering a promising approach to help people achieve lasting freedom from this harmful habit.

Navigating the Desert of Addiction

Nicotine addiction is a complex and challenging condition. This research explores the potential of pre-quit therapies to enhance existing cessation strategies, offering a fresh perspective on this important public health issue. It's like discovering a hidden spring of water in the desert, bringing renewed hope and energy to the journey of quitting smoking.

Dr. Camel's Conclusion

This study sheds light on the potential of pre-quit pharmacotherapies to revolutionize smoking cessation. It's like discovering a new and improved compass, guiding smokers toward a more successful path to freedom from nicotine addiction. The research offers a promising new approach to this long-standing public health challenge, paving the way for a healthier future for countless individuals.

Date :
  1. Date Completed 2016-07-06
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

26689281

DOI: Digital Object Identifier

PMC4687305

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.